308 related articles for article (PubMed ID: 12922115)
21. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice.
Prescott JF; Patterson MC; Nicholson VM; Morein B; Yager JA
Vet Microbiol; 1997 Jun; 56(3-4):213-25. PubMed ID: 9226836
[TBL] [Abstract][Full Text] [Related]
22. Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
Cardoso SA; Oliveira AF; Ruas LP; Trevisani MM; De Oliveira LL; Hanna ES; Roque-Barreira MC; Soares SG
Vaccine; 2013 Sep; 31(41):4528-35. PubMed ID: 23933366
[TBL] [Abstract][Full Text] [Related]
23. Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection.
Oliveira AF; Ruas LP; Cardoso SA; Soares SG; Roque-Barreira MC
PLoS One; 2010 Jan; 5(1):e8644. PubMed ID: 20072623
[TBL] [Abstract][Full Text] [Related]
24. Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals.
Sanz MG; Oliveira AF; Page A; Horohov DW
Vet Rec; 2014 Nov; 175(19):485. PubMed ID: 25117301
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of a peptide-ELISA based upon N-terminal B-cell epitope of the VapA protein for diagnosis of Rhodococcus equi pneumonia in foals.
Phumoonna T; Muscatello G; Chicken C; Gilkerson JR; Browning GF; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2006 Apr; 53(3):126-32. PubMed ID: 16629724
[TBL] [Abstract][Full Text] [Related]
26. Immunoprophylaxis of Rhodococcus equi pneumonia in foals.
Becú T; Polledo G; Gaskin JM
Vet Microbiol; 1997 Jun; 56(3-4):193-204. PubMed ID: 9226834
[TBL] [Abstract][Full Text] [Related]
27. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.
Jacks S; Giguère S; Crawford PC; Castleman WL
Clin Vaccine Immunol; 2007 Jun; 14(6):669-77. PubMed ID: 17409222
[TBL] [Abstract][Full Text] [Related]
28. Current understanding of the equine immune response to Rhodococcus equi. An immunological review of R. equi pneumonia.
Dawson TRMY; Horohov DW; Meijer WG; Muscatello G
Vet Immunol Immunopathol; 2010 May; 135(1-2):1-11. PubMed ID: 20064668
[TBL] [Abstract][Full Text] [Related]
29. Serum Antibody Activity against Poly-
Cohen ND; Kahn SK; Cywes-Bentley C; Ramirez-Cortez S; Schuckert AE; Vinacur M; Bordin AI; Pier GB
Microbiol Spectr; 2021 Sep; 9(1):e0063821. PubMed ID: 34319137
[TBL] [Abstract][Full Text] [Related]
30. Antigenic analysis of Rhodococcus equi preparations using different horse sera.
Fontanals AM; Becú T; Polledo G; Gaskin CK; Braun M
Vet Microbiol; 1997 Jun; 56(3-4):247-55. PubMed ID: 9226839
[TBL] [Abstract][Full Text] [Related]
31. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.
Cauchard S; Bermúdez-Humarán LG; Blugeon S; Laugier C; Langella P; Cauchard J
Vaccine; 2011 Dec; 30(1):95-102. PubMed ID: 22019740
[TBL] [Abstract][Full Text] [Related]
32. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals.
Jacks S; Giguère S; Prescott JF
Clin Vaccine Immunol; 2007 Apr; 14(4):369-74. PubMed ID: 17301216
[TBL] [Abstract][Full Text] [Related]
33. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
[TBL] [Abstract][Full Text] [Related]
34. Recognition of a B-cell epitope of the VapA protein of Rhodococcus equi in newborn and experimentally infected foals.
Phumoonna T; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2005 Aug; 52(6):291-5. PubMed ID: 16219093
[TBL] [Abstract][Full Text] [Related]
35. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals.
Caston SS; McClure SR; Martens RJ; Chaffin MK; Miles KG; Griffith RW; Cohen ND
Vet Ther; 2006; 7(4):361-75. PubMed ID: 17216591
[TBL] [Abstract][Full Text] [Related]
36. Immunization by intrabronchial administration to 1-week-old foals of an unmarked double gene disruption strain of Rhodococcus equi strain 103+.
Pei Y; Nicholson V; Woods K; Prescott JF
Vet Microbiol; 2007 Nov; 125(1-2):100-10. PubMed ID: 17560744
[TBL] [Abstract][Full Text] [Related]
37. Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA)-enriched antigens.
Fernandez AS; Prescott JF; Nicholson VM
Vet Microbiol; 1997 Jun; 56(3-4):187-92. PubMed ID: 9226833
[TBL] [Abstract][Full Text] [Related]
38. Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.
Mealey RH; Stone DM; Hines MT; Alperin DC; Littke MH; Leib SR; Leach SE; Hines SA
Vaccine; 2007 Oct; 25(43):7582-97. PubMed ID: 17889970
[TBL] [Abstract][Full Text] [Related]
39. Analyses of lipid rafts, Toll-like receptors 2 and 4, and cytokines in foals vaccinated with Virulence Associated Protein A/CpG oligonucleotide vaccine against Rhodococcus equi.
Kaur N; Townsend H; Lohmann K; Marques F; Singh B
Vet Immunol Immunopathol; 2013 Dec; 156(3-4):182-9. PubMed ID: 24422228
[TBL] [Abstract][Full Text] [Related]
40. Mouse lung infection model to assess Rhodococcus equi virulence and vaccine protection.
González-Iglesias P; Scortti M; MacArthur I; Hapeshi A; Rodriguez H; Prescott JF; Vazquez-Boland JA
Vet Microbiol; 2014 Aug; 172(1-2):256-64. PubMed ID: 24852140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
